Trial Profile
Phase II a study of ARM210 in patients with Duchenne muscular dystrophy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs ARM 210 (Primary)
- Indications Duchenne muscular dystrophy
- Focus Therapeutic Use
- Sponsors ARMGO Pharma
- 11 Dec 2015 New trial record